COVID-19 Cash Crisis Leaves UK Research Charities On The Cusp
Could Lose A Generation Of Scientists
Over 150 medical charities including the British Heart Foundation and Cancer Research UK are forecasting a 41% decrease in their research budgets over the next year and are demanding £310m in 2020/21 from the UK government as part of a matched funding program.
You may also be interested in...
Bristol-Myers Squibb is to give away more medicines to uninsured US patients, Cancer Research UK tells of funding hardship, Oxford Biomedica joins a consortium to rapidly develop a vaccine, while a Korean company works on a stem cell therapy.
The appointment of Belén Garijo as CEO of the German major from May next year is a small but significant step on the road to addressing gender inequality at the very top level of management in the world of big pharma.
Galapagos and Gilead's JAK inhibitor has been approved for rheumatoid arthritis in the second and third biggest pharma markets, softening the blow somewhat of rejection from the US FDA in the biggest market last month.